BRIEF-DBV Technologies says FDA gives fast track status to Viaskin Milk

* Results of phase I/II clinical study of Viaskin Milk should be presented in H2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.